Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90.
The chemotherapy of lymphatic filariasis relies upon drugs such as diethylcarbamazine and ivermectin that largely target the microfilarial stages of the parasite, necessitating continued treatment over the long reproductive life span of the adult worm. The identification of compounds that target adu...
Saved in:
Main Authors: | Tony Taldone (Author), Victoria Gillan (Author), Weilin Sun (Author), Anna Rodina (Author), Pallav Patel (Author), Kirsty Maitland (Author), Kerry O'Neill (Author), Gabriela Chiosis (Author), Eileen Devaney (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2010-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
by: Victoria Gillan, et al.
Published: (2014) -
Efficacy of subcutaneous doses and a new oral amorphous solid dispersion formulation of flubendazole on male jirds (Meriones unguiculatus) infected with the filarial nematode Brugia pahangi.
by: Chelsea Fischer, et al.
Published: (2019) -
FRET Assays for the Identification of <i>C. albicans</i> HSP90-Sba1 and <i>Human</i> HSP90α-p23 Binding Inhibitors
by: Philip Kohlmann, et al.
Published: (2024) -
Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
by: Elizabeth Bilsland, et al.
Published: (2016) -
C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
by: Yingjuan Fan, et al.
Published: (2017)